Lido Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Lido Advisors's RMD Position: Q2 2026 in Review
Lido Advisors reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $146K and leaving 2,112 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.
Lido Advisors first reported a position in RMD in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.23M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Lido Advisors held 2,112 shares of ResMed worth $412K as of Q2 2026.
- Lido Advisors sold 704 ResMed shares in Q2 2026, an estimated $146K.
- ResMed made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #1587 holding.
- Lido Advisors first reported a position in ResMed in Q2 2020 and has held it in 22 quarters since.
- Lido Advisors's ResMed position peaked at $1.23M in Q3 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.